Symbol
| ELOVL5
| contributors: mct - updated : 16-12-2021
|
HGNC name
| ELOVL family member 5, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)
|
HGNC id
| 21308
|
corresponding disease(s)
|
SCA38
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
 
| fusion
|  
|  
|  
|
fused with MLL in acute myelogemous leukemia | tumoral
|  
|  
| --over
|  
|
in mesenchymal-type gastric cancer cells (GCs), leading to ferroptosis sensitization | |
Variant & Polymorphism
| rs735860 associated with primary open-angle glaucoma ( |
|
|
Candidate gene
Marker
| epigenetic biomarker for the risk of type 2 diabetes mellitus | Therapy target
| | |
| Elovl5 expression was increased in cellular and mouse models of induced obesity-related diabetes |